Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock with a market cap of $2,007+, returning 14,421%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 14,420.96% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Diginex Limited Ordinary Shares (DGNX) | 5,719.72% |
DeFi Development (DFDV) | 2,479.88% |
Zepp Health (ZEPP) | 2,084.62% |
WW International, Inc Common Stock (WW) | 1,959.54% |
Abits (ABTS) | 1,428.21% |
Oncology Institute (TOI) | 1,197.39% |
FiEE (FIEE) | 1,156.88% |
Abivax SA American Depositary Shares (ABVX) | 1,094.89% |
Lizhi (SOGP) | 778.79% |
Nanobiotix (NBTX) | 777.81% |
Global Interactive Technologies (GITS) | 769.29% |
Above Food Ingredients Inc Common Stock (ABVE) | 740% |
Nova Lifestyle I (NVFY) | 736.61% |
Thayer Ventures Acquisition (TVACW) | 704.36% |
TMC the metals (TMC) | 700% |
Epsium Enterprise Limited Ordinary Shares (EPSM) | 640.85% |
Airnet Technology (ANTE) | 627.88% |
Dominari (DOMH) | 613.1% |
mF International Limited Ordinary Shares (MFI) | 586.3% |
Better Home & Finance (BETR) | 579.63% |
Palvella Therapeutics (PVLA) | 544.7% |
ThredUp (TDUP) | 538.19% |
Oklo (OKLO) | 534.81% |
